208 related articles for article (PubMed ID: 9358223)
1. Changes in keratin expression during the development of benign prostatic hyperplasia.
Xue Y; Smedts F; Umbas R; Aalders TW; Debruyne FM; de la Rosette JJ; Schalken JA
Eur Urol; 1997; 32(3):332-8. PubMed ID: 9358223
[TBL] [Abstract][Full Text] [Related]
2. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.
Verhagen AP; Ramaekers FC; Aalders TW; Schaafsma HE; Debruyne FM; Schalken JA
Cancer Res; 1992 Nov; 52(22):6182-7. PubMed ID: 1384957
[TBL] [Abstract][Full Text] [Related]
3. Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples.
Festuccia C; Angelucci A; Gravina GL; Muzi P; Miano R; Vicentini C; Bologna M
Int J Oncol; 2005 May; 26(5):1353-62. PubMed ID: 15809728
[TBL] [Abstract][Full Text] [Related]
4. Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate.
Xue Y; Verhofstad A; Lange W; Smedts F; Debruyne F; de la Rosette J; Schalken J
Am J Pathol; 1997 Dec; 151(6):1759-65. PubMed ID: 9403726
[TBL] [Abstract][Full Text] [Related]
5. Keratin immunoreactivity in the benign and neoplastic human prostate.
Brawer MK; Peehl DM; Stamey TA; Bostwick DG
Cancer Res; 1985 Aug; 45(8):3663-7. PubMed ID: 2410099
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia and prostatic cancer tissues].
Zhen B; Shen Y; Zhang YM; Zhu CH; Liu ZL
Zhonghua Nan Ke Xue; 2006 May; 12(5):416-20. PubMed ID: 16755871
[TBL] [Abstract][Full Text] [Related]
7. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
[TBL] [Abstract][Full Text] [Related]
9. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
10. Keratin patterns in prostatic hyperplasia and adenocarcinoma.
Svanholm H; Nielsen B; Starklint H
APMIS Suppl; 1988; 4():100-8. PubMed ID: 2465010
[TBL] [Abstract][Full Text] [Related]
11. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
12. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
[TBL] [Abstract][Full Text] [Related]
13. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
[TBL] [Abstract][Full Text] [Related]
14. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
Botticelli AR
Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
[TBL] [Abstract][Full Text] [Related]
15. Expression of basal cell keratins in human prostate cancer metastases and cell lines.
van Leenders GJ; Aalders TW; Hulsbergen-van de Kaa CA; Ruiter DJ; Schalken JA
J Pathol; 2001 Dec; 195(5):563-70. PubMed ID: 11745692
[TBL] [Abstract][Full Text] [Related]
16. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
[TBL] [Abstract][Full Text] [Related]
17. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
18. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
[TBL] [Abstract][Full Text] [Related]
19. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the leptin and leptin receptor expressions in prostate tissues.
Hoon Kim J; Lee SY; Myung SC; Kim YS; Kim TH; Kim MK
Asian J Androl; 2008 Nov; 10(6):923-8. PubMed ID: 18958356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]